Best Marketing Agencies for Fertility, Dermatology and Regenerative Clinics in 2026

Who are the best marketing agencies for specialty clinics?

Ten agencies compete seriously for specialty clinic work in 2026: ClinicAds, Tandem Medical Marketing, IVFgrowth, MD Connect, Healthcare Success, Cardinal Digital Marketing, Intrepy Healthcare Marketing, Practice Growth Co, Doc Digital Solutions, and Influx Marketing. They separate into four groups: fertility specialists, vein and vascular lead generators, regenerative medicine specialists working under FDA claim limits, and multi-specialty healthcare firms that count dermatology among many verticals.

The table below records each agency's public positioning, the proof it publishes about itself, whether any price appears on its site, and the kind of clinic it fits. Proof columns quote what each agency publishes. ClinicAds has verified none of these figures, and no number in the table should be read as a result a clinic would repeat.

What should a specialty clinic look for in an agency?

A specialty clinic should judge an agency on five things: whether the agency measures consults rather than leads, whether it can report on a window longer than the platform default, who reviews a medical claim before the ad runs, whether it signs a business associate agreement, and whether it has run the specific specialty rather than healthcare in general. An agency that answers only the last of those five is selling category familiarity, not a system.

The list is shaped that way because specialty economics do not behave like med spa economics. A med spa books an appointment this week. A fertility clinic, a regenerative practice, or a vein center sells into a decision that takes 30 to 180 days, which means the number on the platform dashboard at day 7 describes a fraction of the cohort. ClinicAds figures here are agency averages, not guarantees.

• ·Consults, not leads. A form fill from someone still reading about IVF is not the same object as a booked consult, and only one of the two can be priced against revenue.
• ·A window longer than 7 days. ClinicAds measures specialty cohorts across 30 to 180 days end to end, because the platform default closes long before the decision does.
• ·A named claims reviewer. The FTC Health Products Compliance Guidance published on 20 December 2022 requires competent and reliable scientific evidence for health claims, and treats anecdotal evidence and animal studies as insufficient.
• ·A signed BAA. Meta and Google do not sign business associate agreements, which is why protected health information has to be stripped server-side before any event reaches an ad platform.
• ·Specialty-specific reps. Fertility, dermatology, regenerative, vein, and vision are five different buying decisions, and an agency that has run one has not necessarily run the others.

Which agency fits which specialty?

Specialty decides the shortlist more than agency size does. Only 2 of the 10 firms reviewed name more than two of the five specialty lines on the pages read, so the honest answer for most clinics is a short list of two or three firms rather than a market survey.

• ·Fertility and IVF: IVFgrowth for a pay-per-lead structure, Tandem Medical Marketing for a published rate card with IVF case figures, MD Connect where infertility sits alongside an existing lead channel.
• ·Dermatology: Cardinal Digital Marketing for multi-location and private-equity-backed groups, Intrepy Healthcare Marketing for named-physician search, Influx Marketing where the cosmetic side is cash-pay and creative-led.
• ·Regenerative medicine: Doc Digital Solutions or Practice Growth Co, both of which lead with claim wording and FDA limits rather than with volume.
• ·Vein and vascular: MD Connect for scale, Healthcare Success for programs that have to balance insurance-covered medical work against elective cosmetic work.
• ·Vision and ophthalmology: Intrepy Healthcare Marketing and Tandem Medical Marketing are the two on this list that name eye care at all.
• ·Measurement is the constraint rather than volume: ClinicAds, which reports on qualified consults across the full window instead of on platform-attributed leads.

What do these agencies actually publish as proof?

Seven of the 10 agencies publish at least one number about their own work, and 3 publish none on the pages read. The shape of those numbers matters more than the count. Most are percentage lifts against an unstated baseline, such as a 77 percent conversion-rate increase or a 575 percent increase in ad conversions, or aggregate totals such as more than 2 million leads generated since 2008. A percentage lift tells a clinic what changed at one account and nothing about what a consult costs.

Two agencies publish a figure denominated in the unit a specialty clinic actually bills. ClinicAds publishes $200 to $600 per qualified consult on $4,000 to $15,000 a month in media. IVFgrowth publishes a relative version, stating that each qualified lead typically costs less than 1 percent of a clinic's average treatment revenue. Practice Growth Co sits between the two, publishing a 42 percent reduction in cost per consultation without publishing the level it fell to.

Zero of the 10 publish a figure measured across the 30 to 180 day window. That absence is the most useful thing in the table, because it means a clinic comparing these agencies on published proof is comparing numbers that all stop before the specialty decision finishes. ClinicAds figures are agency averages, not guarantees.

Why do so few specialty agencies publish a price?

Eight of the 10 agencies publish no dollar figure anywhere in their public positioning. The standard reason given across healthcare marketing is that scope varies by specialty, market count, and whether creative production is included. The practical effect is that a clinic owner cannot build a shortlist without booking five sales calls first, which is a cost the owner pays and the agency does not.

Two publish. Tandem Medical Marketing lists $1,250 a month or 12 percent of ad spend for Google Ads, $750 a month for its core SEO tier, $750 for a flat-fee audit, and $150 to $250 an hour for consulting. That is Tandem's own published rate card and nothing more; it is not evidence of a market rate, and ClinicAds has not verified it. ClinicAds publishes a fixed $15,000 for a 90-day install, payable as $1,250 a month across 12 months, with no required retainer afterward.

IVFgrowth publishes a structure rather than a number, stating no monthly retainers and no setup fees, with payment tied to qualified leads that match a clinic's treatment profile. For a fertility clinic that has never bought media at volume, a structure with no floor is a materially different risk than a retainer, and it is worth asking what counts as qualified before signing.

Which agencies name HIPAA, BAAs, or server-side tracking?

Five of the 10 agencies name HIPAA somewhere on the pages read, and the depth varies sharply. IVFgrowth publishes the most specific claim, describing a HIPAA-compliant pipeline and listing HIPAA, CCPA, and TCPA together. Doc Digital Solutions describes HIPAA-safe patient acquisition systems. Cardinal Digital Marketing refers to helping clients build a HIPAA-compliant tech stack. Tandem Medical Marketing names HIPAA-compliant conversion tracking inside its published IVF playbook. MD Connect lists data privacy and regulatory work as an expertise area without naming HIPAA on the vein page read.

One agency of the 10, ClinicAds, names business associate agreements, server-side Google Tag Manager, and the Meta Conversions API together as one architecture. The distinction is not pedantic. A HIPAA badge describes an intention, while a BAA is a contract and server-side tagging is a mechanism, and only the second two survive a question about how a specific conversion event reached Meta without carrying a patient identifier.

A specialty clinic should ask that question directly during the pitch. An agency that cannot describe what leaves the browser, what leaves the server, and what the ad platform receives is not equipped to run tracking for a covered entity, regardless of how strong its creative work is.

What does FTC enforcement change about agency choice?

Enforcement moves the claims question out of the legal review and into the media plan, because the claims at issue in specialty enforcement are advertising claims. In January 2025, a federal court ordered the co-founders of the Stem Cell Institute of America and their companies to pay $5,155,146 in civil penalties and refunds and banned them from marketing stem cell treatments, in an action brought by the FTC alongside the Georgia Attorney General. An earlier FTC settlement in October 2018 against a California regenerative medicine operator carried a $3.31 million judgment over claims made for amniotic stem cell therapy.

Fertility marketing sits under the same substantiation standard. On 20 May 2021 the FTC and the FDA sent joint warning letters to five companies over claims that their products could treat infertility, including a claim that a supplement could improve IVF success rates. Those letters targeted supplement sellers rather than clinics, but the standard applied is the one a clinic's ad copy is also held to, and the FTC's press release noted civil penalties of up to $43,792 per violation for deceptive disease claims.

Three of the 10 agencies describe anything resembling claims review before launch. Practice Growth Co names FDA limits on efficacy claims for regenerative treatments. Doc Digital Solutions describes careful treatment wording and education-first content. ClinicAds runs claims-substantiation review before every launch. The other seven treat claim wording as the clinic's problem while keeping the media fee.

• ·$5,155,146 in civil penalties and refunds ordered against stem cell marketers in January 2025.
• ·$3.31 million judgment in the FTC's October 2018 amniotic stem cell settlement.
• ·Five joint FTC and FDA warning letters over fertility product claims on 20 May 2021.
• ·3 of 10 agencies reviewed describe a claims-review step on the pages read.

How does ClinicAds compare to the other specialty agencies?

ClinicAds is the narrowest firm on this list and the most specific about measurement. ClinicAds does not run public relations, does not staff an enterprise creative bench, and does not serve health systems. ClinicAds builds the acquisition system inside a clinic's own ad accounts, tracked server-side under a signed BAA, runs claims-substantiation review before launch, and reports cost per qualified consult across the full 30 to 180 day window rather than platform-attributed leads at day 7.

Where a clinic would be better served elsewhere, the honest answer is elsewhere. A dermatology group adding its eleventh location needs the multi-location bench at Cardinal Digital Marketing more than it needs ClinicAds. A vein center that wants raw volume through an existing channel should call MD Connect. A fertility clinic that cannot fund a retainer until volume exists should look hard at the IVFgrowth model. A clinic that simply wants a published rate card and a competent Google account should read Tandem's pricing page. ClinicAds is the right call when the measurement is wrong, the claims exposure is unresolved, or the clinic wants the system built inside its own accounts and handed over rather than rented indefinitely. All ClinicAds figures are agency averages, not guarantees.

When should a specialty clinic not hire an agency?

Three conditions make an agency the wrong purchase this quarter. The first is an intake team that cannot reach a new inquiry inside a few minutes, because a specialty inquiry that waits until tomorrow has usually contacted two other clinics by then and paid media makes that leak more expensive rather than less. The second is a treatment page that cannot survive claims review, where the fix is copy and consent rather than media. The third is a media budget under roughly $4,000 a month, where agency fees consume the share of spend that should be buying data across a long window.

A clinic in any of those three positions gets more from a fixed-scope build or a paid audit than from a 12-month retainer. The retainer earns its place once intake holds, the claims are defensible, and the constraint is genuinely the ability to buy and measure consult volume.

How should a specialty clinic run the agency search?

Run the search as a short structured process rather than a sequence of open-ended sales calls. Five steps, roughly two weeks, and the order matters: name the constraint before hearing any pitch, because an undefined constraint gets defined by whoever presents first.

• ·1. Write the constraint in one sentence: visibility, consult volume, cost per consult, claims exposure, or measurement across the window.
• ·2. Shortlist three agencies that name the specific specialty, not three that rank first for a generic healthcare marketing query.
• ·3. Ask each for cost per qualified consult in that specialty, and note who answers with a percentage lift instead of a figure.
• ·4. Ask who reviews a medical claim before launch, and what happens to the launch calendar when review sends copy back.
• ·5. Ask how a conversion event reaches Meta without carrying protected health information, and buy a paid audit before a 12-month retainer.